Geno J Germano Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Geno J Germano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Geno J Germano. Geno J Germano is Pres.-US Pharm. & Wom. Health. in WYETH ($WYE) and Group President in PFIZER INC ($PFE) and Director in MEDICINES CO /DE ($MDCO) and President in INTREXON CORP ($XON) and Director in PRECISION BIOSCIENCES INC ($DTIL) and in Sage Therapeutics, Inc. ($SAGE) and Director in Bioverativ Inc. ($BIVV).
Latest Insider Trading Transactions of Geno J Germano
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIVV, MDCO, PFE, XON, DTIL, SAGE, WYE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | DTIL | PRECISION BIOSCIEN ... | Germano Geno J | Director | Option Exercise | A | 8.07 | 32,800 | 264,696 | 32,800 | |
Jun 11 2020 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Mar 12 2020 | DTIL | PRECISION BIOSCIEN ... | Germano Geno J | Director | Option Exercise | A | 7.57 | 71,776 | 543,344 | 71,776 | |
Jan 06 2020 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Option Exercise | D | 34.81 | 8,410 | 292,752 | 0 | |
Jan 06 2020 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Option Exercise | D | 33.86 | 9,141 | 309,514 | 0 | |
Jan 06 2020 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Option Exercise | D | 30.90 | 27,243 | 841,809 | 0 | |
Jan 06 2020 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Sell | D | 0.00 | 7,429 | 0 | 0 | 7.4 K to 0 (-100.00 %) |
Jun 06 2019 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 03 2019 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Option Exercise | A | 34.81 | 8,410 | 292,752 | 8,410 | |
Jun 03 2019 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Grant | A | 0.00 | 3,663 | 0 | 7,429 | 3.8 K to 7.4 K (+97.27 %) |
Jan 04 2019 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 89.33 | 878 | 78,432 | 878 | ||
Jun 08 2018 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 154.06 | 10,000 | 1,540,600 | 10,000 | ||
Jun 04 2018 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Option Exercise | A | 33.86 | 9,141 | 309,514 | 9,141 | |
Jun 04 2018 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Grant | A | 0.00 | 3,766 | 0 | 3,766 | 0 to 3.8 K |
Mar 08 2018 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | D | 55.04 | 21,729 | 1,195,964 | 0 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | D | 0.00 | 5,455 | 0 | 0 | |
Feb 02 2018 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | A | 0.00 | 5,455 | 0 | 5,455 | |
Nov 20 2017 | MDCO | MEDICINES CO /DE | Germano Geno J | Director | Option Exercise | A | 30.90 | 27,243 | 841,809 | 27,243 | |
Jun 08 2017 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
May 15 2017 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | A | 55.04 | 21,729 | 1,195,964 | 21,729 | |
Sep 26 2016 | XON | INTREXON CORP | Germano Geno J | President | Option Exercise | A | 29.94 | 1,000,000 | 29,940,000 | 1,000,000 | |
Jul 19 2016 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 42.22 | 20,883 | 881,680 | 20,883 | ||
Jun 03 2016 | XON | INTREXON CORP | Germano Geno J | President | Option Exercise | A | 29.94 | 2,000,000 | 59,880,000 | 2,000,000 | |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Option Exercise | A | 34.59 | 120,805 | 4,178,645 | 120,805 | |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Option Exercise | A | 34.59 | 144,928 | 5,013,060 | 144,928 | |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Option Exercise | M | 17.69 | 83,333 | 1,474,161 | 0 | |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Payment of Exercise | F | 33.47 | 32,840 | 1,099,155 | 308,254 | 341.1 K to 308.3 K (-9.63 %) |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Payment of Exercise | F | 34.66 | 24,856 | 861,509 | 341,094 | 366 K to 341.1 K (-6.79 %) |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Payment of Exercise | F | 34.66 | 6,474 | 224,389 | 365,950 | 372.4 K to 366 K (-1.74 %) |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Grant | A | 0.00 | 17,893 | 0 | 372,424 | 354.5 K to 372.4 K (+5.05 %) |
Feb 27 2015 | PFE | PFIZER INC | Germano Geno J | Group President | Buy | M | 17.69 | 83,333 | 1,474,161 | 354,531 | 271.2 K to 354.5 K (+30.73 %) |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 44.56 | 50,000 | 2,228,000 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 56.00 | 40,000 | 2,240,000 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 48.22 | 30,000 | 1,446,600 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 43.57 | 30,000 | 1,307,100 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 40.22 | 36,000 | 1,447,920 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 41.05 | 20,000 | 821,000 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 34.68 | 1 | 35 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 60.71 | 22,000 | 1,335,510 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 56.53 | 20,000 | 1,130,500 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 56.59 | 18,000 | 1,018,688 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | D | 0.00 | 1,929 | 0 | 0 | |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Sell | D | 0.00 | 1,531 | 0 | 0 | 1.5 K to 0 (-100.00 %) |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Sell | D | 0.00 | 20,557 | 0 | 0 | 20.6 K to 0 (-100.00 %) |
Oct 19 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Sell | D | 49.58 | 23,000 | 1,140,340 | 20,557 | 43.6 K to 20.6 K (-52.80 %) |
Apr 29 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Payment of Exercise | F | 42.10 | 1,524 | 64,160 | 43,382 | 44.9 K to 43.4 K (-3.39 %) |
Mar 03 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Payment of Exercise | F | 41.14 | 2,082 | 85,653 | 44,857 | 46.9 K to 44.9 K (-4.44 %) |
Mar 03 2009 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Grant | A | 0.00 | 6,800 | 0 | 46,939 | 40.1 K to 46.9 K (+16.94 %) |
Nov 26 2008 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Sell | S | 35.89 | 5,000 | 179,450 | 40,079 | 45.1 K to 40.1 K (-11.09 %) |
Apr 28 2008 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Option Exercise | A | 44.56 | 50,000 | 2,228,000 | 50,000 | |
Apr 23 2008 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Payment of Exercise | F | 44.93 | 1,149 | 51,625 | 44,924 | 46.1 K to 44.9 K (-2.49 %) |
Mar 04 2008 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Payment of Exercise | F | 42.54 | 1,788 | 76,062 | 45,999 | 47.8 K to 46 K (-3.74 %) |
Mar 04 2008 | WYE | WYETH | Germano Geno J | Pres.-US Pharm. & W ... | Grant | A | 0.00 | 5,840 | 0 | 47,787 | 41.9 K to 47.8 K (+13.92 %) |
Page: 1